Cargando…

Mesothelial Inclusions in Pelvic Lymph Nodes Initially Diagnosed as Metastatic Prostate Cancer; the Utility of Second Opinions and Genomic Testing in the Setting of Unexpected Results

Benign mesothelial inclusions in pelvic lymph nodes may be mistaken for metastatic disease in the setting of pelvic malignancy. In this case-report a patient with Low-Risk prostate cancer (confirmed by biopsy and genomic testing) underwent radical prostatectomy with pelvic lymph node dissection. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Joudi, Fadi, Denes, Bela S., Mies, Carolyn, Yang, Zhiming, Shindel, Alan W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5148772/
https://www.ncbi.nlm.nih.gov/pubmed/27957426
http://dx.doi.org/10.1016/j.eucr.2016.10.016
_version_ 1782473877657485312
author Joudi, Fadi
Denes, Bela S.
Mies, Carolyn
Yang, Zhiming
Shindel, Alan W.
author_facet Joudi, Fadi
Denes, Bela S.
Mies, Carolyn
Yang, Zhiming
Shindel, Alan W.
author_sort Joudi, Fadi
collection PubMed
description Benign mesothelial inclusions in pelvic lymph nodes may be mistaken for metastatic disease in the setting of pelvic malignancy. In this case-report a patient with Low-Risk prostate cancer (confirmed by biopsy and genomic testing) underwent radical prostatectomy with pelvic lymph node dissection. The initial pathological diagnosis was organ-confined Gleason 3 + 3 = 6 cancer with metastasis to a pelvic lymph node. Upon review of the pathological specimen and immunohistochemical staining the lymph node tissue concerning for metastatic disease was recharacterized as mesothelial in origin. This case illustrates the importance of second opinions and immunohistochemistry for unexpected or unusual pathological findings.
format Online
Article
Text
id pubmed-5148772
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-51487722016-12-12 Mesothelial Inclusions in Pelvic Lymph Nodes Initially Diagnosed as Metastatic Prostate Cancer; the Utility of Second Opinions and Genomic Testing in the Setting of Unexpected Results Joudi, Fadi Denes, Bela S. Mies, Carolyn Yang, Zhiming Shindel, Alan W. Urol Case Rep Oncology Benign mesothelial inclusions in pelvic lymph nodes may be mistaken for metastatic disease in the setting of pelvic malignancy. In this case-report a patient with Low-Risk prostate cancer (confirmed by biopsy and genomic testing) underwent radical prostatectomy with pelvic lymph node dissection. The initial pathological diagnosis was organ-confined Gleason 3 + 3 = 6 cancer with metastasis to a pelvic lymph node. Upon review of the pathological specimen and immunohistochemical staining the lymph node tissue concerning for metastatic disease was recharacterized as mesothelial in origin. This case illustrates the importance of second opinions and immunohistochemistry for unexpected or unusual pathological findings. Elsevier 2016-12-06 /pmc/articles/PMC5148772/ /pubmed/27957426 http://dx.doi.org/10.1016/j.eucr.2016.10.016 Text en © 2016 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Oncology
Joudi, Fadi
Denes, Bela S.
Mies, Carolyn
Yang, Zhiming
Shindel, Alan W.
Mesothelial Inclusions in Pelvic Lymph Nodes Initially Diagnosed as Metastatic Prostate Cancer; the Utility of Second Opinions and Genomic Testing in the Setting of Unexpected Results
title Mesothelial Inclusions in Pelvic Lymph Nodes Initially Diagnosed as Metastatic Prostate Cancer; the Utility of Second Opinions and Genomic Testing in the Setting of Unexpected Results
title_full Mesothelial Inclusions in Pelvic Lymph Nodes Initially Diagnosed as Metastatic Prostate Cancer; the Utility of Second Opinions and Genomic Testing in the Setting of Unexpected Results
title_fullStr Mesothelial Inclusions in Pelvic Lymph Nodes Initially Diagnosed as Metastatic Prostate Cancer; the Utility of Second Opinions and Genomic Testing in the Setting of Unexpected Results
title_full_unstemmed Mesothelial Inclusions in Pelvic Lymph Nodes Initially Diagnosed as Metastatic Prostate Cancer; the Utility of Second Opinions and Genomic Testing in the Setting of Unexpected Results
title_short Mesothelial Inclusions in Pelvic Lymph Nodes Initially Diagnosed as Metastatic Prostate Cancer; the Utility of Second Opinions and Genomic Testing in the Setting of Unexpected Results
title_sort mesothelial inclusions in pelvic lymph nodes initially diagnosed as metastatic prostate cancer; the utility of second opinions and genomic testing in the setting of unexpected results
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5148772/
https://www.ncbi.nlm.nih.gov/pubmed/27957426
http://dx.doi.org/10.1016/j.eucr.2016.10.016
work_keys_str_mv AT joudifadi mesothelialinclusionsinpelviclymphnodesinitiallydiagnosedasmetastaticprostatecancertheutilityofsecondopinionsandgenomictestinginthesettingofunexpectedresults
AT denesbelas mesothelialinclusionsinpelviclymphnodesinitiallydiagnosedasmetastaticprostatecancertheutilityofsecondopinionsandgenomictestinginthesettingofunexpectedresults
AT miescarolyn mesothelialinclusionsinpelviclymphnodesinitiallydiagnosedasmetastaticprostatecancertheutilityofsecondopinionsandgenomictestinginthesettingofunexpectedresults
AT yangzhiming mesothelialinclusionsinpelviclymphnodesinitiallydiagnosedasmetastaticprostatecancertheutilityofsecondopinionsandgenomictestinginthesettingofunexpectedresults
AT shindelalanw mesothelialinclusionsinpelviclymphnodesinitiallydiagnosedasmetastaticprostatecancertheutilityofsecondopinionsandgenomictestinginthesettingofunexpectedresults